Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,667 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (773)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02181465 | Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.(CC1A&B) | completed | Phase 2 | 11 | Cancer Advances Inc.INDUSTRY | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00165854 | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eisai LimitedINDUSTRY | 3 | Jun 27, 2014 |
| clinicaltrials |
| NCT00439517 | Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.(FUTURE) | completed | Phase 2 | 302 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 14 | Jun 27, 2014 | clinicaltrials |
| NCT00901147 | Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma | completed | Phase 2 | 25 | Singapore General HospitalOTHER | 3 | Jun 27, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00256334 | Resveratrol for Patients With Colon Cancer | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT01208194 | Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma(IMPACT) | completed | Phase 2 | 59 | Mologen AGINDUSTRY | 6 | Jun 20, 2014 | clinicaltrials |
| NCT01175317 | Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and Rectum(HOC) | completed | Phase 4 | 58 | Maastricht University Medical CenterOTHER | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 17, 2014 | clinicaltrials |
| NCT01887158 | Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection(PEGOP) | completed | Phase 4 | 116 | Ospedale Santa Maria delle CrociOTHER | 1 | Jun 17, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT01005225 | Genetic Investigation of Solid Tumors Cohort | completed | — | 25 | Scripps Translational Science InstituteOTHER | 1 | Jun 12, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01134276 | Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers | completed | N/A | 211 | Seoul National University HospitalOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01225744 | Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy(eSCOUT) | completed | Phase 2 | 47 | The Christie NHS Foundation TrustOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00675012 | NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 24 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00054639 | Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 53 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183833 | Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00336141 | Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 10 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00737828 | Cardiopulmonary Exercise Testing and Preoperative Risk Stratification | completed | N/A | 228 | University College London HospitalsOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT01116687 | RO4929097 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00504153 | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 19, 2014 | clinicaltrials |
| NCT00352638 | Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer | completed | Phase 3 | 660 | Fox Chase Cancer CenterOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | completed | Phase 2 | 54 | Regione LombardiaOTHER | 1 | May 12, 2014 | clinicaltrials |
| NCT01134640 | A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment | completed | — | 286 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 9, 2014 | clinicaltrials |
| NCT01859442 | The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness | completed | Early Phase 1 | 12 | Michelle MossaOTHER_GOV | 1 | May 6, 2014 | clinicaltrials |
| NCT01835925 | Rectal Cancer Consortium | completed | — | 12 | Brown UniversityOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00814619 | Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer | completed | Phase 2 | 68 | Swiss Cancer InstituteOTHER | 2 | Apr 30, 2014 | clinicaltrials |
| NCT01231919 | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02122523 | Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-Dye | completed | N/A | 25 | Amsterdam UMC, location VUmcOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT02118064 | Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma(CC6) | completed | Phase 2 | 161 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00134069 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01372553 | Guilford Genomic Medicine Initiative (GGMI)(GGMI) | completed | — | 1,184 | The Moses H. Cone Memorial HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01667198 | Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators | completed | N/A | 40 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00109226 | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Apr 8, 2014 | clinicaltrials |
| NCT01552200 | Performance Evaluation of the NaviAid™ G-Eye System | completed | N/A | 126 | Smart Medical Systems Ltd.INDUSTRY | 2 | Apr 8, 2014 | clinicaltrials |
| NCT02106806 | Zinc Supplementation on Markers of Oxidative Stress in Post Operative Colorectal Cancer During Chemotherapy Cycles | completed | N/A | 55 | University of Sao PauloOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT01325909 | Exercise Training in Colorectal Cancer Patients | completed | N/A | 35 | Michelle MossaOTHER_GOV | 1 | Apr 7, 2014 | clinicaltrials |
| NCT01803009 | Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool(CRC-RAT) | completed | N/A | 63 | Indiana UniversityOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT01941966 | A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. | completed | Phase 2 | 51 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Mar 28, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00096967 | A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | completed | Phase 3 | 100 | Genentech, Inc.INDUSTRY | 0 | Mar 26, 2014 | clinicaltrials |
| NCT01434264 | Evaluating Personalized Effect of an Individualized Intervention | completed | N/A | 247 | University of Southern DenmarkOTHER | 1 | Mar 10, 2014 | clinicaltrials |
| NCT00003950 | Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 16 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01434147 | Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy | completed | Phase 2 | 25 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Mar 7, 2014 | clinicaltrials |
| NCT02076529 | Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting | completed | N/A | 51 | Chonnam National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Jul 4, 2014source: clinicaltrials